Literature DB >> 30380403

Integrated Stress Response Activity Marks Stem Cells in Normal Hematopoiesis and Leukemia.

Peter van Galen1, Nathan Mbong2, Antonia Kreso3, Erwin M Schoof4, Elvin Wagenblast2, Stanley W K Ng5, Gabriela Krivdova6, Liqing Jin2, Hiromitsu Nakauchi7, John E Dick8.   

Abstract

Lifelong maintenance of the blood system requires equilibrium between clearance of damaged hematopoietic stem cells (HSCs) and long-term survival of the HSC pool. Severe perturbations of cellular homeostasis result in rapid HSC loss to maintain clonal purity. However, normal homeostatic processes can also generate lower-level stress; how HSCs survive these conditions remains unknown. Here we show that the integrated stress response (ISR) is uniquely active in HSCs and facilitates their persistence. Activating transcription factor 4 (ATF4) mediates the ISR and is highly expressed in HSCs due to scarcity of the eIF2 translation initiation complex. Amino acid deprivation results in eIF2α phosphorylation-dependent upregulation of ATF4, promoting HSC survival. Primitive acute myeloid leukemia (AML) cells also display eIF2 scarcity and ISR activity marks leukemia stem cells (LSCs) in primary AML samples. These findings identify a link between the ISR and stem cell survival in the normal and leukemic contexts.
Copyright © 2018 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  amino acid deprivation; human hematopoietic stem cells; integrated stress response; leukemia stem cells

Mesh:

Substances:

Year:  2018        PMID: 30380403     DOI: 10.1016/j.celrep.2018.10.021

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  28 in total

1.  Aggregation-induced integrated stress response rejuvenates culture-expanded human mesenchymal stem cells.

Authors:  Brent M Bijonowski; Qin Fu; Xuegang Yuan; Jerome Irianto; Yan Li; Samuel C Grant; Teng Ma
Journal:  Biotechnol Bioeng       Date:  2020-07-05       Impact factor: 4.530

Review 2.  Amino acid metabolism in hematologic malignancies and the era of targeted therapy.

Authors:  Yoko Tabe; Philip L Lorenzi; Marina Konopleva
Journal:  Blood       Date:  2019-08-15       Impact factor: 22.113

3.  Ceramide: improving Bcl-2 inhibitor therapy.

Authors:  Brian M Barth
Journal:  Blood       Date:  2022-06-30       Impact factor: 25.476

4.  Relapse-Fated Latent Diagnosis Subclones in Acute B Lineage Leukemia Are Drug Tolerant and Possess Distinct Metabolic Programs.

Authors:  Laura García-Prat; Robert J Vanner; Jeffrey Wintersinger; Esmé Waanders; Stephanie M Dobson; Zhaohui Gu; Jessica McLeod; Olga I Gan; Ildiko Grandal; Debbie Payne-Turner; Michael N Edmonson; Xiaotu Ma; Yiping Fan; Veronique Voisin; Michelle Chan-Seng-Yue; Stephanie Z Xie; Mohsen Hosseini; Sagi Abelson; Pankaj Gupta; Michael Rusch; Ying Shao; Scott R Olsen; Geoffrey Neale; Steven M Chan; Gary Bader; John Easton; Cynthia J Guidos; Jayne S Danska; Jinghui Zhang; Mark D Minden; Quaid Morris; Charles G Mullighan; John E Dick
Journal:  Cancer Discov       Date:  2020-02-21       Impact factor: 39.397

Review 5.  Unfolded Protein Response in Leukemia: From Basic Understanding to Therapeutic Opportunities.

Authors:  Ali Khateb; Ze'ev A Ronai
Journal:  Trends Cancer       Date:  2020-06-13

Review 6.  Post-Transcriptional Regulation of Homeostatic, Stressed, and Malignant Stem Cells.

Authors:  Bernadette A Chua; Inge Van Der Werf; Catriona Jamieson; Robert A J Signer
Journal:  Cell Stem Cell       Date:  2020-02-06       Impact factor: 24.633

Review 7.  Hormetic endoplasmic reticulum stress in hematopoietic stem cells.

Authors:  Larry L Luchsinger
Journal:  Curr Opin Hematol       Date:  2021-11-01       Impact factor: 3.284

Review 8.  ER Stress and Unfolded Protein Response in Leukemia: Friend, Foe, or Both?

Authors:  Kelly Féral; Manon Jaud; Céline Philippe; Doriana Di Bella; Stéphane Pyronnet; Kevin Rouault-Pierre; Laurent Mazzolini; Christian Touriol
Journal:  Biomolecules       Date:  2021-01-30

Review 9.  Extinguishing the Embers: Targeting AML Metabolism.

Authors:  Rachel Culp-Hill; Angelo D'Alessandro; Eric M Pietras
Journal:  Trends Mol Med       Date:  2020-10-26       Impact factor: 11.951

10.  Actinomycin D Targets NPM1c-Primed Mitochondria to Restore PML-Driven Senescence in AML Therapy.

Authors:  Domitille Rérolle; Caroline Berthier; Rita Hleihel; Takashi Sakamoto; Hsin-Chieh Wu; Samuel Quentin; Shirine Benhenda; Claudia Morganti; Chengchen Wu; Lidio Conte; Sylvie Rimsky; Marie Sebert; Emmanuelle Clappier; Sylvie Souquere; Stéphanie Gachet; Jean Soulier; Sylvère Durand; Jennifer J Trowbridge; Paule Bénit; Pierre Rustin; Hiba El Hajj; Emmanuel Raffoux; Lionel Ades; Raphael Itzykson; Hervé Dombret; Pierre Fenaux; Olivier Espeli; Guido Kroemer; Lorenzo Brunetti; Tak W Mak; Valérie Lallemand-Breitenbach; Ali Bazarbachi; Brunangelo Falini; Keisuke Ito; Maria Paola Martelli; Hugues de Thé
Journal:  Cancer Discov       Date:  2021-12-01       Impact factor: 38.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.